Clinical Trial Update: Ceftolozane-Tazobactam for Directed Treatment of Pseudomonas Aeruginosa Bacteremia and Pneumonia in Patients With Hematological Malignancies and Hematopoietic Stem Cell Transplantation [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating ceftolozane-tazobactam for directed treatment of Pseudomonas aeruginosa bacteremia and pneumonia in patients with hematologic malignanc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacteremia
• Hematologic Malignancy
• Pneumonia
• Pseudomonas Aeruginosa Infection

Drugs mentioned

• Zerbaxa (ceftolozane/tazobactam) (ceftolozane/tazobactam)

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Pneumonia, Hematologic Malignancy | Phase 4 | Status: TERMINATED | Results posted: 2026-01-21